The Protein Production Core's mission is to produce heterologously expressed, purified and functionally reconstituted human neuronal GABAA and glycine (GlyR) receptors in the large quantities required for photolabeling and sequencing. This is a challenging resource-intensive objective best handled by a central facility. During the current period the Core has thoroughly developed several inducible mammalian cell lines capable of expressing large quantities of GABAA receptors bearing accessible purification epitopes. With such cell lines the successive steps of solubilization, purification and reconstitution have been optimized. GABAA receptors with ?1?3 and ?1?3?2L subunit compositions are now in production and have enabled new general anesthetic sites to be found. The Core can now routinely fulfill its overall specific aim of supplying Projects 1 &2 with nanomole quantities of well characterized, purified receptors functionally reconstituted that are required for photolabeling studies. The Core has had initial success with a new cell line expressing ?4?3? GABAA receptors. The specific receptors to be produced in this way are all human neuronal members of the Cys-loop superfamily and will be produced in HEK293 TetR cells, ensuring correct processing. The focus is on the inhibitory receptors, specifically the GABAA and glycine receptors: synaptic receptors composed of GABAA subunits ?1?3?2L, and extrasynaptic receptors composed of GABAA subunits ?4?3?. In addition ?1?3 and ?4?3 receptors will act as controls. GlyR cell lines will express ?1? subunits. Selected subunits will be mutated in order to: (1) determine subunit stoichiometry using site directed spin labeling, and (2) to aid the projects distinguish between the five pseudo symmetric transmembrane intersubunit general anesthetic binding sites. A subsidiary goal is to support the needs of investigators (primarily Project 3) using electrophysiological techniques. They will be able to achieve efficiencies by using the Core's resources to design wild type and mutant constructs for their studies This latter service will not detract from the Core's main labor-intensive goal of developing stable, inducible cell lines and over-expressing human neuronal receptors for photolabeling and biochemical studies. The Core will be situated in the Mallinckrodt Pharmacology Laboratory at MGH. This Core supports the PPG's overall aim of defining the structure activity relationships of drugs that target the various different anesthetic-binding sites on GABAA and glycine (GlyR) receptors in order to improve the safety of these dangerous drugs.

Agency
National Institute of Health (NIH)
Type
Research Program Projects (P01)
Project #
2P01GM058448-16
Application #
8742131
Study Section
Special Emphasis Panel (ZGM1)
Project Start
Project End
Budget Start
Budget End
Support Year
16
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Eaton, Megan M; Germann, Allison L; Arora, Ruby et al. (2016) Multiple Non-Equivalent Interfaces Mediate Direct Activation of GABAA Receptors by Propofol. Curr Neuropharmacol 14:772-80
Zhang, Xi (2016) Instant Integrated Ultradeep Quantitative-structural Membrane Proteomics Discovered Post-translational Modification Signatures for Human Cys-loop Receptor Subunit Bias. Mol Cell Proteomics 15:3665-3684
Forman, Stuart A; Miller, Keith W (2016) Mapping General Anesthetic Sites in Heteromeric γ-Aminobutyric Acid Type A Receptors Reveals a Potential For Targeting Receptor Subtypes. Anesth Analg 123:1263-1273
Chiara, David C; Jounaidi, Youssef; Zhou, Xiaojuan et al. (2016) General Anesthetic Binding Sites in Human α4β3δ γ-Aminobutyric Acid Type A Receptors (GABAARs). J Biol Chem 291:26529-26539
Amlong, Corey A; Perkins, Mark G; Houle, Timothy T et al. (2016) Contrasting Effects of the γ-Aminobutyric Acid Type A Receptor β3 Subunit N265M Mutation on Loss of Righting Reflexes Induced by Etomidate and the Novel Anesthetic Barbiturate R-mTFD-MPAB. Anesth Analg 123:1241-1246
Ziemba, Alexis M; Forman, Stuart A (2016) Correction for Inhibition Leads to an Allosteric Co-Agonist Model for Pentobarbital Modulation and Activation of α1β3γ2L GABAA Receptors. PLoS One 11:e0154031
Nourmahnad, Anahita; Stern, Alex T; Hotta, Mayo et al. (2016) Tryptophan and Cysteine Mutations in M1 Helices of α1β3γ2L γ-Aminobutyric Acid Type A Receptors Indicate Distinct Intersubunit Sites for Four Intravenous Anesthetics and One Orphan Site. Anesthesiology 125:1144-1158
Forman, Stuart A; Chiara, David C; Miller, Keith W (2015) Anesthetics target interfacial transmembrane sites in nicotinic acetylcholine receptors. Neuropharmacology 96:169-77
Hamouda, Ayman K; Wang, Ze-Jun; Stewart, Deirdre S et al. (2015) Desformylflustrabromine (dFBr) and [3H]dFBr-Labeled Binding Sites in a Nicotinic Acetylcholine Receptor. Mol Pharmacol 88:1-11
Liu, K; Jounaidi, Y; Forman, S A et al. (2015) Etomidate uniquely modulates the desensitization of recombinant α1β3δ GABA(A) receptors. Neuroscience 300:307-13

Showing the most recent 10 out of 104 publications